New horizons in the treatment of osteosarcoma
PS Meltzer, LJ Helman - New England Journal of Medicine, 2021 - Mass Medical Soc
Osteosarcoma Osteosarcoma, which is most common in people 10 to 30 years of age, is
generally treated with resection and adjuvant chemotherapy. Detection of gene …
generally treated with resection and adjuvant chemotherapy. Detection of gene …
Increased risk of cancer in dogs and humans: A consequence of recent extension of lifespan beyond evolutionarily determined limitations?
Cancer is among the most common causes of death for dogs (and cats) and humans in the
developed world, even though it is uncommon in wildlife and other domestic animals. We …
developed world, even though it is uncommon in wildlife and other domestic animals. We …
Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer
R Liu, Y Hu, T Liu, Y Wang - BMC cancer, 2021 - Springer
Backgrounds Osteosarcomas are one of the most common primary malignant tumors of
bone. It primarily occurs in children and adolescents, with the second highest incidence …
bone. It primarily occurs in children and adolescents, with the second highest incidence …
Roles of parathyroid hormone-related protein (PTHrP) and its receptor (PTHR1) in normal and tumor tissues: Focus on their roles in osteosarcoma
AA Al-Khan, NR Al Balushi, SJ Richardson… - Frontiers in veterinary …, 2021 - frontiersin.org
Osteosarcoma (OS) is the most common primary bone tumor and originates from bone
forming mesenchymal cells and primarily affects children and adolescents. The 5-year …
forming mesenchymal cells and primarily affects children and adolescents. The 5-year …
Single-cell profiling of tumor microenvironment heterogeneity in osteosarcoma identifies a highly invasive subcluster for predicting prognosis
J Guo, H Tang, P Huang, J Guo, Y Shi, C Yuan… - Frontiers in …, 2022 - frontiersin.org
Osteosarcoma is the most common malignant bone tumor in adolescents, and metastasis is
the key reason for treatment failure and poor prognosis. Once metastasis occurs, the 5-year …
the key reason for treatment failure and poor prognosis. Once metastasis occurs, the 5-year …
[HTML][HTML] A simple, universal and multifunctional template agent for personalized treatment of bone tumors
W Liu, S Dong, W Hu, M Gao, T Li, Q Ji, X Yang, D Qi… - Bioactive Materials, 2022 - Elsevier
Bone tumors occur in bone or its accessory tissues. Benign bone tumors are easy to cure
and have good prognosis, while malignant bone tumors develop rapidly and have poor and …
and have good prognosis, while malignant bone tumors develop rapidly and have poor and …
New information on paleopathologies in non-avian theropod dinosaurs: a case study on South American abelisaurids
Studies on pathological fossil bones have allowed improving the knowledge of physiology
and ecology, and consequently the life history of extinct organisms. Among extinct …
and ecology, and consequently the life history of extinct organisms. Among extinct …
A pathological ulna of Amurosaurus riabinini from the Upper Cretaceous of Far Eastern Russia
F Bertozzo, I Bolotsky, YL Bolotsky… - Historical …, 2023 - Taylor & Francis
Bone fractures are the most common type of injuries preserved in the dinosaur fossil record.
Poor healing of deep lesions could lead to infection and misalignment of the fracture parts …
Poor healing of deep lesions could lead to infection and misalignment of the fracture parts …
Chronic fracture and osteomyelitis in a large‐bodied ornithomimosaur with implications for the identification of unusual endosteal bone in the fossil record
T Chinzorig, KA Beguesse, A Canoville… - The Anatomical …, 2023 - Wiley Online Library
Paleopathological diagnoses provide key information on the macroevolutionary origin of
disease as well as behavioral and physiological inferences that are inaccessible via direct …
disease as well as behavioral and physiological inferences that are inaccessible via direct …
[HTML][HTML] Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression
X An, W Wu, P Wang, A Mahmut, J Guo, J Dong… - Biomedical Journal, 2024 - Elsevier
Background Dysregulation of long non-coding RNAs (lncRNAs) is an important component
of tumorigenesis. Aberrant expression of lncRNA taurine upregulated gene 1 (lncTUG1) has …
of tumorigenesis. Aberrant expression of lncRNA taurine upregulated gene 1 (lncTUG1) has …